| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 0.602 +57.81% on 03/13/25 | | 2.190 -56.62% on 03/10/25 | -0.874 (-47.92%) since 03/07/25 |
| 3-Month | 0.602 +57.81% on 03/13/25 | | 2.950 -67.80% on 01/15/25 | -0.948 (-49.95%) since 01/08/25 |
| 52-Week | 0.602 +57.81% on 03/13/25 | | 10.000 -90.50% on 04/10/24 | -4.810 (-83.51%) since 04/08/24 |
Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta to treat or prevent severe...
Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, today announces it will...
Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, today announces positive...
| 3rd Resistance Point | 1.869 |
| 2nd Resistance Point | 1.575 |
| 1st Resistance Point | 1.262 |
| Last Price | 0.950 |
| 1st Support Level | 0.655 |
| 2nd Support Level | 0.361 |
| 3rd Support Level | 0.048 |
| 52-Week High | 10.000 |
| Fibonacci 61.8% | 6.410 |
| Fibonacci 50% | 5.301 |
| Fibonacci 38.2% | 4.192 |
| Last Price | 0.950 |
| 52-Week Low | 0.602 |